INNOVUS PHARMACEUTICALS, INC. (INNV) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 127 transactions totaling $2.2M, demonstrating a bullish sentiment with $1.4M in net insider flow. The most recent transaction on Dec 1, 2025 involved a transaction of 5,054 shares valued at $27.6K.
No significant insider buying has been recorded for INNV in the recent period.
No significant insider selling has been recorded for INNV in the recent period.
Based on recent SEC filings, insider sentiment for INNV is bullish with an Insider Alignment Score of 82/100 and a net flow of $1.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at INNOVUS PHARMACEUTICALS, INC. (INNV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading INNV stock, having executed 127 transactions in the past 90 days. The most active insider is Nicole Damato (Executive), who has made 24 transactions totaling $706.7K.
Get notified when executives and directors at INNV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | T. Blair Patrick | Executive | Payment | 5,054 | $5.47 | $27.6K | |
| Nov 14, 2025 | Anthony Scarbrough Michael | Executive | Sale | 33,000 | $4.90 | $161.7K | |
| Sep 1, 2025 | T. Blair Patrick | Executive | Payment | 5,056 | $3.83 | $19.4K | |
| Aug 15, 2025 | Damato Nicole | Executive | Payment | 14,303 | $3.43 | $49.1K | |
| Jul 16, 2025 | T. Blair Patrick | Executive | Award | 137,299 | $N/A | $0 | |
| Jul 15, 2025 | Damato Nicole | Executive | Award | 125,598 | $N/A | $0 | |
| Jul 15, 2025 | Anthony Scarbrough Michael | Executive | Award | 119,617 | $N/A | $0 | |
| Jul 1, 2025 | Ellis Bush John | Executive | Award | 25,316 | $N/A | $0 | |
| Jul 1, 2025 | G. Carlson James | Executive | Award | 25,316 | $N/A | $0 | |
| Jul 1, 2025 | Fontneau Patricia | Executive | Award | 25,316 | $N/A | $0 | |
| Jul 1, 2025 | Moore Kennedy Edward Jr | Executive | Award | 25,316 | $N/A | $0 | |
| Jul 1, 2025 | Sparks Teresa | Executive | Award | 25,316 | $N/A | $0 | |
| Jul 1, 2025 | B. Tavenner Marilyn | Executive | Award | 25,316 | $N/A | $0 | |
| Jul 1, 2025 | C. Zoretic Richard | Executive | Award | 25,316 | $N/A | $0 | |
| Sep 17, 2024 | Damato Nicole | Executive | Sale | 7,521 | $6.00 | $45.1K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 20 | $1.8M | 53.6% |
Payment(F) | 23 | $1.1M | 34.3% |
Sale(S) | 12 | $400.3K | 12.1% |
Award(A) | 56 | $6 | 0.0% |
Other(J) | 8 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insiders at INNOVUS PHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 28 insiders making 127 transactions totaling $1.8M in purchases versus $400.3K in sales, the net buying activity of $1.4M signals strong executive confidence. Nicole Damato (Executive) leads the buying activity with $706.7K in transactions across all time.